SEC Form 4 · accession 0001179110-18-009896
Strongbridge Biopharma plc · SBBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fredric J. Cohen
Officer — Chief Medical Officer
Period of report
Jun 13, 2018
Accepted (ET)
Jul 25, 2018 · 3:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001634432
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jun 13, 2018 | F | 2,174 | $6.30 | D | 15,174 | D |
Table II — derivative securities
No Table II lines on this filing.